Natural Killer Cells

Deauvieau, Florence, Fenis, Aurore, Dalençon, François, Burdin, Nicolas, Vivier, Eric, Kerdiles, Yann, Florence Deauvieau, Aurore Fenis, François Dalençon, Nicolas Burdin, Eric Vivier, Yann Kerdiles

Since their discovery in the late 1970s, in vivo studies on mouse natural killer (NK) cell almost entirely relied on the use of depleting antibodies and were associated with significant limitations. More recently, large-scale gene-expression analyses allowed the identification of NKp46 as one of the best markers of NK cells across mammalian species. Since then, NKp46 has been shown to be expressed on other subsets of innate lymphoid cells (ILCs) such as the closely related ILC1 and the mucosa-associated NCR(+) ILC3. Based on this marker, several mouse models specifically targeting NKp46-expressing cell have recently been produced. Here, we review recent advances in the generation of models of deficiency in NKp46-expressing cells and their use to address the role of NK cells in immunity, notably on the regulation of adaptive immune responses.